Govt Job: For D.Pharm , B.Pharm under Medical Education | Pay Rs 60,500 per month

The Directorate of Medical Education, Assam, Training and Research, Assam was established in the year 1984 under the control of Health & Family Welfare Department, Government of Assam.

Post: Pharmacist

Online applications are invited from the citizens of India as defined under Article 5 and 6 of the Constitution of India for filling up of vacancies of different Grade-Ill posts (technical & non-technical) in existing vacant posts and newly create the Directorate of Medical Education. Assam and different Medical Colleges and Hospitals as well as Dental Nursing Colleges, Paramedical Institutes etc. of the Sate under the establishment of the Directorate of Medical E Assam

Pharmacist
No of Posts :
 06 [UR-4, ST(p)-01, OBC/MOBC-01]

Requisite qualification : HSSLC (Sc) or equivalent with Diploma in Pharmacy from Govt, recognized Institute

Pay Scale : Rs. 14,000-Rs. 60,500
Grade Pay : Rs. 7400/-

Chemist
No of Posts :
 01 [UR-01]

Requisite qualification : B.Sc with Chemistry/B.Pharm from a recognized Institute
Pay Scale : Rs. 14,000-Rs. 60,500
Grade Pay : Rs. 8700/-

Application Fee :No fee is required to be paid.

Selection Process :
Selection process shall be notified in the official website of the Directorate of Medical Education. Assam (dme.assam.gov.in) in due course of time.

The online application form shall also be uploaded in the same portal shortly. The candidates are requested to keep a watch in the portal.

Terms & Conditions :
Intending candidates are to check the official website of the Directorate of Medical Education, Assam (dme.assam.gov.in) I for detail terms & conditions and other criteria’s of the recruitment process which will be published in due course of time.

Last Date :18th February, 2022

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’